Skip to content

Hong Kong, Singapore, Shanghai, Sydney, London

  • IOS
  • android 16Android
  • Enquiry / Get Quote
  • 中文
    • 繁中
    • 简中
  • International
    • Singapore Office

Hong Kong, Singapore, Shanghai, Sydney, London

  • IOS
  • android 16Android
  • Enquiry / Get Quote
  • 中文
    • 繁中
    • 简中
  • International
    • Singapore Office
Valtech-Valuation-Consulting
  • Valtech Home
  • About Us
    • About Us
    • Valtech Leadership Team
    • Our Market Positioning
  • Video
    • Valtech Corporate Videos
  • Valuation Services

    Business Valuation

    • Business Valuation and Transaction Advisory
    • Business Valuation for the AI Sector
    • Business Valuation by Use Cases
    • 409A Valuation Services
    • Biotech and Life Science
    • Business valuation for Notifiable Transactions
    • Business Valuation by Industry
    • Startup Valuation
    • Private Equity Portfolio Valuation
    • Purchase Price Allocation (PPA)
    • Litigation and Tax Compliance
    • Valuation Review

    Financial Assets / Liabilities

    • Financial Instruments Valuation
    • Derivatives Valuation
    • FCN Valuations with Confidence
    • Valuation of Employee Share Options (ESO)
    • Valuation of Convertible Notes or Bonds
    • Valuation of Preference Shares
    • Litigation and Tax Compliance
    • Valuation Review
    • LSP Valuation (HK New Legistlation)
    • Valuation of Tokenisation
    • Valuation of Investment in Key Man Insurance
    • Expected Credit Loss Assessment
      • Forward-Looking Information for ECL
      • Expected Credit Loss Advisory Solutions
    • Valuation of Projected Benefit Obligation (PBO)

    Assets Valuation

    • Property, Plant and Equipment Valuation
    • Mining Valuation and Project Coordination
    • Biological Assets Valuation
    • Crypto Asset Valuation
    • Security Token Valuation Service
    • Business Valuation
      • Business Valuation and Transaction Advisory
      • Business Valuation by Industry
      • Business Valuation of Software-as-a-Service (SaaS) Company 
      • Brand Valuation
      • Independent Business Valuation for Notifiable Transactions
      • Purchase Price Allocation (PPA)
      • Biotech Valuation & Healthcare Valuation
      • Private Equity Portfolio Valuation
      • Valuation for Private Funds
      • Litigation and Tax Compliance
      • Valuation Review
    • Financial Assets Valuation
      • Financial Instruments Valuation
      • Valuation of Employee Share Options (ESO) or Stock Warrants 
      • ECL
        • Expected Credit Loss Assessment
        • Expected Credit Loss Advisory Solutions
        • Forward-Looking Information for ECL
        • ECL – Mortgage Loan / Margin Finance
      • Derivatives Valuation
      • Convertible Bonds
      • LSP Valuation HKAS19
      • Incremental Borrowing Rate (IBR)
      • Valuation of Tokenisation
      • Valuation of Projected Benefit Obligation (PBO)
      • Valuation of Investment in Key Man Insurance
    • Assets Valuation
      • Property, Plant and Equipment Valuation
      • Mining Valuation and Project Coordination
      • Biological Assets Valuation
      • Crypto Asset Valuation
  • Cap Table
  • App
    • Free Calculation Tool inside Valtech Mobile and iPad App
    • Legacy Web Applications
      • Employee Share Option
      • WACC Discount Rate Calculator
      • Calculator for LSP or SP Payment
  • Case References / Insights
    • Corporate News
    • Valuation Track Record by Industry
    • Business Valuation Cases
    • Financial Instruments Cases
    • Financial Reporting IFRS and ASC Cases
    • Hong Kong
      • Hong Kong Market
      • Hong Kong Economy and Finance Updates
      • Long Service Payment Valuation (LSP Valuation in Hong Kong)
    • Valuation Glossary
  • Contact
    • Contact Us
    • Get Quote
    • Careers

Valtech’s Top IFRS Valuation Agenda in 2020

Valtech’s Top IFRS Valuation Agenda in 2020
  • Valtech Valuation 2020 Top IFRS Agenda

IFRS 9-compliant NAV Reporting

IFRS 9 requires fund managers and corporate management to recognize financial assets under a new 3-category rule based on a set of criteria. Each category requires substantially different valuation treatments.

  • Amortised Cost / FVOCL /FVPL
  • The historical investment cost becomes less relevant unless referenced as last resort.
  • Management are expected to receive increasing scrutiny on the reported fair value by auditors and regulators, especially during market turbulence (e.g. early 2020).

We have advised fund managers and general partners on determining the adjusted NAV of private funds under an IFRS-compliant framework.

IFRS 9 Expected Credit Losses

IFRS 9 specifies a new impairment model based on the “expected” credit condition instead of the previous “incurred” premise.

  • Management are expected to determine the 12-month and life-time expected credit losses with respect to a 3-stage framework. The losses, if determined material, will reduce the reported net values.
  • “Forward-looking” information becomes essential in deriving the expected credit losses. Macro-economic regressions and scenario analysis are recommended.

We have advised management on the computation and interpretation of such unexpected IFRS losses to their stakeholders.

IAS 36 Impairment of Cash-Generating Units

IAS 36 itself is not a new topic, however it brings up further hassle after the new IFRS 16 Lease has come into effect since 2019.

  • IAS 36 requires management to identify and test the recoverability of the cash-generating units on an annual basis if there is goodwill or assets with perpetual useful lives, or with impairment indications.
  • Under the new IFRS 16, lease agreements in effect will be capitalized as right-of-use assets and their respective payable recognized as a debt-like liabilities.

The combined effect of IAS 36 and the new IFRS 16 poses extra burden for annual tests of the enlarged asset groups (e.g. especially for retail companies). In 2020, we have advised many clients on healthy transition into IFRS 16 from a valuation perspective.

Distressed Assets and Dispute Resolutions

Speculative, subordinated, mezzanine and high-yield investments usually feature huge valuation uncertainties during market turbulence. Investments with delayed or defaulted payment could be reclassified as distressed assets be reported as deep discounts to their original amounts.

  • Investors may seek to justify the discount applied to the value of the distressed investments, with further consideration on the reduced market liquidity.

We provide professionally supported valuation reports which significantly reduce the time burden of the Board of Directors on conducting price discovery research, especially during market turbulence times.

Hybrid Securities and Hard-to-value instruments

Venture capitalists typically invest in the preference shares, redeemable and convertible instruments issued by early-stage companies. Unlike ordinary debt and equity financing, these risky instruments often provide extra protection and variable return with following typical features.

  • Liquidation preference, at 1X/2X or IRR
  • Conversion and auto-conversion
  • Participation or non-participation
  • Return caps and thresholds
  • Early redemption, call & put features

Our derivative specialists are experienced in performing valuations that incorporate complex considerations, such that the value potential of such investments will not be undermined.

Tax and Cross-border Transfer Pricing, BEPS

Statutory requirements on tax valuation and transfer pricing reporting has gained increasing importance.

  • In the mainland PRC, we see an increasing trend that local authorities require taxpayers to obtain an independent opinion on the proposed asset transfer between related-party taxpayers (e.g. subsidiaries under the same group) to justify the arm’s length consideration of the tax amount.
  • In Hong Kong, the Inland Revenue (Amendment) (No. 6) Ordinance 2018 was enacted on 13 July 2018 in relation to the statutory requirement on preparation of a local file on the group’s transfer pricing arrangement (i.e. TP Documentation).

Our tax specialists are experienced in providing Hong Kong tax advisory and transfer pricing study and documentation and another BEPS solutions.

Click here to download full article
Categories: Business Valuation, Financial Reporting IFRS HKFRS|Tags: IFRS, IFRS 9, tax|

Share This Post With Others!

FacebookXLinkedInPinterestEmail

Related Posts

Valtech Valuation Services Posts 2

Valuing Share Awards Issuance for Financial Reporting

July 17th, 2026
Valtech Valuation Services Posts 4

Business Update: Elevating Cross-Border Valuation through Global Expertise and Trusted Judgment

July 10th, 2026
Valtech Valuation Services Posts 3

Better Valuation Models and Programme for Accounting and Audit-Related Valuations

June 24th, 2026
Valtech Valuation Services Posts 2 1

Valtech Case Sharing: AI Sector Market Valuation Assessment for a Cross-Border Transaction

June 22nd, 2026

Contact: Max Tsang

Phone: +852-23889262

Email: max.tsang@valtech-valuation.com

Web: Enquiry / Get Quote

Singapore: Sales

Phone: +65 84949455

Mobile: +65-88891148 (wtsapp)

Email: admin-sg@valtech-valuation.sg

Web: Enquiry / Get Quote

Valtech Mobile App

Valtech Apple App
Valtech Android App

Business Valuation Services

  • Business Valuation and Transaction Advisory
  • Business Valuation for the AI Sector
  • Business Valuation by Use Cases
  • 409A Valuation Services
  • Biotech and Life Science
  • Business valuation for Notifiable Transactions
  • Business Valuation by Industry
  • Startup Valuation
  • Private Equity Portfolio Valuation
  • Purchase Price Allocation (PPA)
  • Litigation and Tax Compliance
  • Valuation Review

Financial Valuation Services

  • Financial Instruments Valuation
  • Derivatives Valuation
  • FCN Valuations with Confidence
  • Valuation of Employee Share Options (ESO)
  • Valuation of Convertible Notes or Bonds
  • Valuation of Preference Shares
  • Litigation and Tax Compliance
  • Valuation Review
  • LSP Valuation (HK New Legistlation)
  • Valuation of Tokenisation
  • Valuation of Investment in Key Man Insurance
  • Expected Credit Loss Assessment
    • Forward-Looking Information for ECL
    • Expected Credit Loss Advisory Solutions
  • Valuation of Projected Benefit Obligation (PBO)

Assets Valuation Services

  • Property, Plant and Equipment Valuation
  • Mining Valuation and Project Coordination
  • Biological Assets Valuation
  • Crypto Asset Valuation
  • Security Token Valuation Service
© Copyright    |    Valtech Valuation Advisory Ltd   |   All Rights Reserved  | 
Page load link
Go to Top